TipRanks
Samjin Pharmaceutical Co., Ltd. (KR:005500)
:005500
South Korea Market
005500
Samjin Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Samjin Pharmaceutical Co., Ltd. (005500) Ratios

― Followers

Samjin Pharmaceutical Co., Ltd. Ratios

KR:005500's free cash flow for Q2 2026 was ₩0.39. For the 2026 fiscal year, KR:005500's free cash flow was decreased by ₩ and operating cash flow was ₩0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.32 1.30 1.00 1.01 1.64
Quick Ratio
 0.59 0.55 0.42 0.46 0.80
Cash Ratio
 0.09 0.08 0.02 0.02 0.03
Solvency Ratio
 0.25 0.24 0.35 0.23 0.24
Operating Cash Flow Ratio
 0.23 0.15 0.24 0.06 0.21
Short-Term Operating Cash Flow Coverage
 0.33 0.21 0.32 0.07 0.39
Net Current Asset Value
₩ 15.54B₩ 11.44B₩ -4.41B₩ -8.36B₩ 3.58B
Leverage Ratios
Debt-to-Assets Ratio
 0.27 0.29 0.29 0.28 0.22
Debt-to-Equity Ratio
 0.43 0.47 0.46 0.45 0.32
Debt-to-Capital Ratio
 0.30 0.32 0.32 0.31 0.24
Long-Term Debt-to-Capital Ratio
 0.09 0.09 <0.01 0.02 0.13
Financial Leverage Ratio
 1.60 1.62 1.62 1.58 1.48
Debt Service Coverage Ratio
 0.18 0.42 0.49 0.34 0.73
Interest Coverage Ratio
 4.46 4.99 6.49 4.41 13.15
Debt to Market Cap
 0.53 0.56 0.53 0.42 0.27
Interest Debt Per Share
 10.63K 11.50K 10.01K 9.50K 7.05K
Net Debt to EBITDA
 6.11 2.78 1.79 3.18 2.31
Profitability Margins
Gross Profit Margin
45.63%49.50%41.82%49.94%42.96%
EBIT Margin
-0.65%7.98%15.74%6.84%9.85%
EBITDA Margin
6.15%14.40%21.38%12.53%13.43%
Operating Profit Margin
6.74%7.98%10.26%6.67%8.46%
Pretax Profit Margin
7.62%7.15%14.15%5.34%9.21%
Net Profit Margin
7.47%7.82%12.72%6.47%7.99%
Continuous Operations Profit Margin
7.47%7.82%12.72%6.49%7.99%
Net Income Per EBT
98.03%109.37%89.90%121.23%86.79%
EBT Per EBIT
113.12%89.53%137.94%79.99%108.81%
Return on Assets (ROA)
4.88%5.14%9.23%4.50%5.39%
Return on Equity (ROE)
8.22%8.32%14.99%7.13%7.95%
Return on Capital Employed (ROCE)
6.33%7.63%11.89%7.08%7.14%
Return on Invested Capital (ROIC)
4.75%5.73%7.35%5.00%5.44%
Return on Tangible Assets
5.11%5.38%9.72%4.73%5.53%
Earnings Yield
9.56%9.99%17.22%6.74%6.74%
Efficiency Ratios
Receivables Turnover
 5.04 4.66 4.92 4.75 4.58
Payables Turnover
 12.89 10.13 11.02 13.13 11.86
Inventory Turnover
 1.60 1.41 1.96 1.84 2.28
Fixed Asset Turnover
 1.72 1.65 1.60 1.52 1.38
Asset Turnover
 0.65 0.66 0.73 0.70 0.67
Working Capital Turnover Ratio
 7.15 13.93 384.22 10.77 3.83
Cash Conversion Cycle
 272.72 301.45 227.72 247.67 209.17
Days of Sales Outstanding
 72.46 78.35 74.19 76.78 79.76
Days of Inventory Outstanding
 228.58 259.13 186.66 198.68 160.19
Days of Payables Outstanding
 28.33 36.03 33.13 27.80 30.78
Operating Cycle
 301.05 337.48 260.85 275.47 239.95
Cash Flow Ratios
Operating Cash Flow Per Share
 2.67K 1.81K 3.03K 643.47 1.36K
Free Cash Flow Per Share
 2.05K 812.91 1.57K -956.50 -1.44K
CapEx Per Share
 624.24 1.00K 1.45K 1.60K 2.80K
Free Cash Flow to Operating Cash Flow
 0.77 0.45 0.52 -1.49 -1.05
Dividend Paid and CapEx Coverage Ratio
 1.88 1.01 1.34 0.27 0.38
Capital Expenditure Coverage Ratio
 4.28 1.81 2.08 0.40 0.49
Operating Cash Flow Coverage Ratio
 0.26 0.16 0.31 0.07 0.20
Operating Cash Flow to Sales Ratio
 0.11 0.07 0.12 0.03 0.06
Free Cash Flow Yield
10.65%4.12%8.69%-4.42%-5.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.37 10.06 5.81 14.83 14.84
Price-to-Sales (P/S) Ratio
 0.79 0.78 0.74 0.96 1.19
Price-to-Book (P/B) Ratio
 0.82 0.83 0.87 1.06 1.18
Price-to-Free Cash Flow (P/FCF) Ratio
 9.46 24.30 11.50 -22.63 -17.85
Price-to-Operating Cash Flow Ratio
 7.25 10.88 5.97 33.65 18.79
Price-to-Earnings Growth (PEG) Ratio
 0.62 -0.27 0.05 -0.96 -0.59
Price-to-Fair Value
 0.82 0.83 0.87 1.06 1.18
Enterprise Value Multiple
 18.92 8.22 5.25 10.84 11.14
Enterprise Value
 360.49B 365.79B 345.90B 396.63B 410.18B
EV to EBITDA
 18.82 8.22 5.25 10.84 11.14
EV to Sales
 1.16 1.18 1.12 1.36 1.50
EV to Free Cash Flow
 13.91 36.73 17.46 -32.02 -22.53
EV to Operating Cash Flow
 10.66 16.45 9.07 47.59 23.72
Tangible Book Value Per Share
 21.99K 21.94K 19.04K 18.92K 20.96K
Shareholders’ Equity Per Share
 23.60K 23.70K 20.75K 20.49K 21.73K
Tax and Other Ratios
Effective Tax Rate
 0.02 -0.09 0.10 -0.21 0.13
Revenue Per Share
 24.60K 25.23K 24.45K 22.56K 21.63K
Net Income Per Share
 1.84K 1.97K 3.11K 1.46K 1.73K
Tax Burden
 0.98 1.09 0.90 1.21 0.87
Interest Burden
 -11.68 0.90 0.90 0.78 0.93
Research & Development to Revenue
 0.07 0.12 0.01 0.01 0.01
SG&A to Revenue
 0.20 0.14 0.13 0.14 0.16
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.45 0.92 0.97 0.44 0.79
Currency in KRW